Literature DB >> 27118362

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.

Min Zhao1, Marie Therese Cooney2, Kerstin Klipstein-Grobusch3, Ilonca Vaartjes4, Dirk De Bacquer5, Johan De Sutter6, Željko Reiner7, Eva Prescott8, Pompilio Faggiano9, Diego Vanuzzo10, Hussam AlFaleh11, Ian Ba Menown12, Dan Gait13, Nana Posogova14, Wayne H-H Sheu15, Dong Zhao16, Huijuan Zuo17, Diederick E Grobbee4, Ian M Graham18.   

Abstract

BACKGROUND: To simplify the assessment of the recording and control of coronary heart disease risk factors in different countries and regions.
DESIGN: The SUrvey of Risk Factors (SURF) is an international clinical audit.
METHODS: Data on consecutive patients with established coronary heart disease from countries in Europe, Asia and the Middle East were collected on a one-page collection sheet or electronically during routine clinic visits. Information on demographics, diagnostic category, risk factors, physical and laboratory measurements, and medications were included and key variables summarized in a Cardiovascular Health Index Score.
RESULTS: Coronary heart disease patients (N = 10,186; 29% women) were enrolled from 79 centres in 11 countries. Recording of risk factors varied considerably: smoking was recorded in over 98% of subjects, while about 20% lacked data on laboratory measurements relevant to cardiovascular disease risk. Sixteen per cent of participants reported smoking, 29% were obese, and 46% had abdominal obesity. Sixty per cent of participants had blood pressure <140/90 mmHg (140/80 mmHg for diabetics), 48% had HbA1c<7%, 30% had low-density lipoprotein <1.8 mmol/l and 17% had a good cardiovascular health index score. There were substantial regional variations. Less than 3% of patients attended cardiac rehabilitation in Asia or the Middle East, compared with 45% in Europe. In Asia, 15% of patients had low-density lipoprotein cholesterol <1.8 mmol/l compared with 33% in Europe and 36% in the Middle East. Variations in medications were noted, with lower use of statins in Asia.
CONCLUSIONS: SURF proved to be practical in daily practice. Results indicated poor control of risk factors with substantial variation between countries, calling for development and implementation of clinical standards of secondary prevention of coronary heart disease. © The European Society of Cardiology 2016.

Entities:  

Keywords:  CHD; SURF; audit; management; recording; risk factors; secondary prevention

Mesh:

Year:  2016        PMID: 27118362     DOI: 10.1177/2047487316647827

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  15 in total

1.  Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!

Authors:  Ahmed AlBadri; Janet Wei; Puja K Mehta; Rashmee Shah; Romana Herscovici; Martha Gulati; Chrisandra Shufelt; Noel Bairey Merz
Journal:  Heart       Date:  2017-09-20       Impact factor: 7.365

Review 2.  The polypill approach - An innovative strategy to improve cardiovascular health in Europe.

Authors:  Valentín Fuster; Francesc Gambús; Aldo Patriciello; Margaretha Hamrin; Diederick E Grobbee
Journal:  BMC Pharmacol Toxicol       Date:  2017-02-07       Impact factor: 2.483

3.  Sex differences in risk factor management of coronary heart disease across three regions.

Authors:  Min Zhao; Ilonca Vaartjes; Ian Graham; Diederick Grobbee; Wilko Spiering; Kerstin Klipstein-Grobusch; Mark Woodward; Sanne Ae Peters
Journal:  Heart       Date:  2017-09-20       Impact factor: 5.994

4.  Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry.

Authors:  Wen Yea Hwong; Zariah Abdul Aziz; Norsima Nazifah Sidek; Michiel L Bots; Sharmini Selvarajah; L Jaap Kappelle; Sheamini Sivasampu; Ilonca Vaartjes
Journal:  BMC Neurol       Date:  2017-11-23       Impact factor: 2.474

5.  Bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?

Authors:  Renata Francik; Jadwiga Kryczyk-Kozioł; Sławomir Francik; Ryszard Gryboś; Mirosław Krośniak
Journal:  Biomed Res Int       Date:  2017-04-26       Impact factor: 3.411

6.  Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data.

Authors:  Vasilios G Athyros; Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  Int J Cardiol       Date:  2020-07-04       Impact factor: 4.164

7.  Determinants of coronary artery disease risk factor management across three world regions.

Authors:  Min Zhao; Ian Graham; Marie Therese Cooney; Diederick E Grobbee; Ilonca Vaartjes; Kerstin Klipstein-Grobusch
Journal:  Heart Asia       Date:  2019-03-08

8.  Prediction of Cardiovascular Disease by the Framingham-REGICOR Equation in the High-Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata.

Authors:  Antonio J Amor; Mercè Serra-Mir; Miguel A Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Montserrat Fitó; Ramón Estruch; Lluis Serra-Majem; Fernando Arós; Nancy Babio; Emilio Ros; Emilio Ortega
Journal:  J Am Heart Assoc       Date:  2017-03-13       Impact factor: 5.501

9.  Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS).

Authors:  Lieven Annemans; Joseph Azuri; Khalid Al-Rasadi; Ibrahim Al-Zakwani; Veronique Daclin; Florence Mercier; Nicolas Danchin
Journal:  Lipids Health Dis       Date:  2020-04-07       Impact factor: 3.876

10.  Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.

Authors:  Anne Grete Semb; Silvia Rollefstad; Eirik Ikdahl; Grunde Wibetoe; Joseph Sexton; Cindy Crowson; Piet van Riel; George Kitas; Ian Graham; Solbritt Rantapää-Dahlqvist; George Athanasios Karpouzas; Elena Myasoedova; Miguel A Gonzalez-Gay; Petros P Sfikakis; Maria G Tektonidou; Argyro Lazarini; Dimitrios Vassilopoulos; Bindee Kuriya; Carol Hitchon; Maria Simona Stoenoiu; Patrick Durez; Virginia Pascual-Ramos; Dionicio Angel Galarza-Delgado; Pompilio Faggiano; Durga Prasanna Misra; Andrew A Borg; Rong Mu; Erkin M Mirrakhimov; Diane Gheta; Karen Douglas; Vikas Agarwal; Svetlana Myasoedova; Lev Krougly; Tatiana Valentinovna Popkova; Alena Tuchyňová; Michal Tomcik; Michal Vrablik; Jiri Lastuvka; Pavel Horak; Helena Kaspar Medkova; Anne M Kerola
Journal:  RMD Open       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.